12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
| 应用 | 稀释度 |
|---|---|
| ELISA | 1.221-5000 ng/ml |
Relatlimab is a Lymphocyte activation gene-3 (LAG-3) inhibitor. It is used in combination with nivolumab to treat melanoma.
Immobilized human LAG-3 at 0.5 μg/ml (50 μL/well) can bind to Relatlimab with a linear range of 1.221 ng/ml-5 μg/ml.
您现在的位置：